Trials / Unknown
UnknownNCT03642912
Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation (Observational Study)
Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation Hämostaseologisches Monitoring Bei Patienten Mit Extrakorporaler Membranoxygenierung
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Coagulation disorders are on top of the list of extracorporeal-membrane oxygenation (ECMO) complications. They contribute significantly to morbidity and mortality of ECMO patients. This observational study aims to evaluate coagulation profiles of ECMO patients treated on the intensive care units of the Department of Anaesthesiology of LMU Munich.
Detailed description
Coagulation disorders are on top of the list of extracorporeal-membrane oxygenation (ECMO) complications. They contribute significantly to morbidity and mortality of ECMO patients. This observational study aims to evaluate coagulation profiles of ECMO patients treated on the intensive care units of the Department of Anaesthesiology of LMU Munich. Adult ECMO patients are included in the study after informed consent. Bleeding and thromboembolic complications as well as treatment details are recorded. Additional coagulation laboratory markers (such as von-Willebrand-factor, ADAMTS13-protease, platelet function tests and thromboelastometric tests) are correlated with clinical signs of bleeding. Regular ultrasound examination of the large vessels are performed to Screen for thrombosis.
Conditions
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2020-09-30
- Completion
- 2022-12-31
- First posted
- 2018-08-22
- Last updated
- 2022-04-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03642912. Inclusion in this directory is not an endorsement.